These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27230658)

  • 21. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
    Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
    Liabeuf S; Lenglet A; Desjardins L; Neirynck N; Glorieux G; Lemke HD; Vanholder R; Diouf M; Choukroun G; Massy ZA;
    Kidney Int; 2012 Dec; 82(12):1297-303. PubMed ID: 22895515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
    Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placental Growth Factor as a Predictor of Cardiovascular Events in Patients with CKD from the NARA-CKD Study.
    Matsui M; Uemura S; Takeda Y; Samejima K; Matsumoto T; Hasegawa A; Tsushima H; Hoshino E; Ueda T; Morimoto K; Okamoto K; Okada S; Onoue K; Okayama S; Kawata H; Kawakami R; Maruyama N; Akai Y; Iwano M; Shiiki H; Saito Y;
    J Am Soc Nephrol; 2015 Nov; 26(11):2871-81. PubMed ID: 25788536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.
    Mafra D; Lobo JC; Barros AF; Koppe L; Vaziri ND; Fouque D
    Future Microbiol; 2014; 9(3):399-410. PubMed ID: 24762311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
    Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
    Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.
    Bech AP; Bouma-de Krijger A; van Zuilen AD; Bots ML; van den Brand JA; Blankestijn PJ; Wetzels JF; Vervloet MG
    J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.
    Sirich TL; Funk BA; Plummer NS; Hostetter TH; Meyer TW
    J Am Soc Nephrol; 2014 Mar; 25(3):615-22. PubMed ID: 24231664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD.
    Tsai YC; Chiu YW; Tsai JC; Kuo HT; Hung CC; Hwang SJ; Chen TH; Kuo MC; Chen HC
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):39-46. PubMed ID: 25512646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.
    Gondouin B; Jourde-Chiche N; Sallee M; Dou L; Cerini C; Loundou A; Morange S; Berland Y; Burtey S; Brunet P; Guieu R; Dussol B
    Nephron; 2015; 131(3):167-74. PubMed ID: 26426087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease.
    Ottosson F; Brunkwall L; Smith E; Orho-Melander M; Nilsson PM; Fernandez C; Melander O
    J Hypertens; 2020 Dec; 38(12):2427-2434. PubMed ID: 32665522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
    Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
    Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.
    Xiong Z; Xu H; Huang X; Ärnlöv J; Qureshi AR; Cederholm T; Sjögren P; Lindholm B; Risérus U; Carrero JJ
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):584-91. PubMed ID: 25637632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uremic Solutes in Chronic Kidney Disease and Their Role in Progression.
    van den Brand JA; Mutsaers HA; van Zuilen AD; Blankestijn PJ; van den Broek PH; Russel FG; Masereeuw R; Wetzels JF
    PLoS One; 2016; 11(12):e0168117. PubMed ID: 28033375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events.
    Wang CP; Lu LF; Yu TH; Hung WC; Chiu CA; Chung FM; Hsu CC; Lu YC; Lee YJ; Houng JY
    J Nephrol; 2013; 26(1):111-8. PubMed ID: 22460182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women.
    Lewis JR; Lim WH; Ueland T; Wong G; Zhu K; Lim EM; Bollerslev J; Prince RL
    PLoS One; 2015; 10(7):e0134266. PubMed ID: 26222774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease.
    Solak Y; Yilmaz MI; Saglam M; Demirbas S; Verim S; Unal HU; Gaipov A; Oguz Y; Kayrak M; Caglar K; Vural A; Turk S; Covic A; Kanbay M
    Nephrology (Carlton); 2013 Nov; 18(11):728-35. PubMed ID: 23848392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease.
    Yeh YC; Huang MF; Liang SS; Hwang SJ; Tsai JC; Liu TL; Wu PH; Yang YH; Kuo KC; Kuo MC; Chen CS
    Neurotoxicology; 2016 Mar; 53():148-152. PubMed ID: 26797588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.